• Tel: 858.663.9055
  • separatorEmail: info@nsjbio.com
  • Tel: 858.663.9055
  • Email: info@nsjbio.com
banner

Cardiovascular Antibodies

Home >> Antibodies >> Cardiovascular Antibodies

Cardiovascular Antibodies

Cardiovascular Antibodies Overview

Cardiovascular Antibodies are essential reagents for exploring the molecular pathways that govern heart function, vascular biology, and blood circulation. Cardiovascular research investigates how cardiomyocytes, endothelial cells, vascular smooth muscle cells, and circulating immune cells coordinate to maintain cardiovascular homeostasis. Dysregulation of these systems contributes to leading global health burdens, including atherosclerosis, myocardial infarction, hypertension, arrhythmias, and heart failure.

The targets of cardiovascular research span structural proteins, ion channels, adhesion molecules, cytokines, growth factors, and enzymes that regulate vascular tone, cardiac contractility, and immune–vascular interactions. The Cardiovascular Antibodies collection provides reliable detection of these proteins, enabling researchers to map disease mechanisms, validate biomarkers, and explore therapeutic strategies.

Why Choose Cardiovascular Antibodies from NSJ Bioreagents?

NSJ Bioreagents offers Cardiovascular Antibodies validated for immunohistochemistry, western blotting, flow cytometry, immunofluorescence, and ELISA. Each Cardiovascular Antibody is subjected to rigorous quality control to ensure specificity, reproducibility, and compatibility across diverse assay platforms.

By selecting Cardiovascular Antibodies from NSJ Bioreagents, scientists gain reagents optimized for clarity and consistency. Our antibodies provide strong staining in cardiac and vascular tissues, reproducible detection in lysates, and robust performance in both discovery and diagnostic workflows. Comprehensive datasheets, validated controls, and optimized protocols further ensure reproducibility in both laboratory and translational settings.

Applications of Cardiovascular Antibodies

The Cardiovascular Antibodies collection supports diverse applications across cardiovascular biology and disease.

1) Cardiac Muscle Biology

  • Cardiovascular Antibodies detect contractile proteins like troponins, myosin heavy chains, and actin isoforms.

  • The Cardiovascular Antibodies support studies of cardiomyocyte differentiation and hypertrophy.

  • Antibodies help clarify mechanisms of contractile dysfunction in heart failure.

2) Vascular Biology and Atherosclerosis

  • Cardiovascular Antibodies highlight adhesion molecules, integrins, and smooth muscle proteins.

  • The Cardiovascular Antibodies support research into endothelial activation and plaque formation.

  • Antibodies validate biomarkers for vascular remodeling and atherogenesis.

3) Inflammation and Immune Regulation

  • Cardiovascular Antibodies detect cytokines, chemokines, and immune cell markers in vascular disease.

  • The Cardiovascular Antibodies support studies of immune–vascular cross-talk.

  • Antibodies clarify mechanisms of chronic inflammation in cardiovascular pathology.

4) Electrophysiology and Ion Channel Biology

  • Cardiovascular Antibodies identify sodium, potassium, and calcium channels in cardiac tissue.

  • The Cardiovascular Antibodies support studies of arrhythmias and conduction disorders.

  • Antibodies provide tools for mapping ion channel dysregulation in disease.

5) Fibrosis and Tissue Remodeling

  • Cardiovascular Antibodies detect extracellular matrix proteins and remodeling enzymes.

  • The Cardiovascular Antibodies support research into fibrosis after myocardial infarction.

  • Antibodies validate therapeutic strategies targeting tissue repair.

6) Translational and Clinical Research

  • Cardiovascular Antibodies are integrated into biomarker-driven cardiovascular studies.

  • The Cardiovascular Antibodies support patient stratification in clinical trials.

  • Antibodies ensure reproducibility and reliability in translational workflows.

Why Are Cardiovascular Antibodies Important?

Cardiovascular biology connects molecular pathways with systemic health outcomes. The Cardiovascular Antibodies portfolio equips researchers to investigate proteins critical for heart and vascular function.

In cardiac research, Cardiovascular Antibodies highlight contractile proteins and biomarkers of heart injury. In vascular biology, they identify molecules involved in endothelial activation and atherosclerosis. In immunology, the Cardiovascular Antibodies clarify immune–vascular interactions driving chronic disease.

Clinically, cardiovascular biomarkers remain indispensable for diagnosis, prognosis, and therapeutic monitoring. Reliable Cardiovascular Antibodies ensure reproducibility, bridging basic science with translational and clinical medicine.

Conclusion

Cardiovascular disease remains the leading cause of morbidity and mortality worldwide, and antibodies are key tools for advancing understanding and treatment. The Cardiovascular Antibodies collection provides validated reagents for studying heart and vascular biology across basic research, diagnostics, and translational applications. By ensuring specificity, reproducibility, and assay versatility, these antibodies remain indispensable for advancing cardiovascular science and improving clinical outcomes.

 
Found all antibodies, displaying 2951 to 2960
Decorin Antibody / DCN (clone MSVA-537R)
Catalog No : V6066
Applications : IHC
Reactivity : Human
Format : Purified
Recrabbitmono
Immunohistochemistry of DCN Antibody for IHC in human tissue microarrays. Recombinant monoclonal clone MSVA-537R was applied to formalin-fixed, paraffin-embedded normal and cancer tissues. In normal tissues, Decorin expression is predominantly observed within stromal extracellular matrix compartments, highlighting collagen-rich connective tissue surrounding glands, vessels, and muscle bundles, while epithelial and parenchymal cells show minimal staining. In cancer tissues, variable stromal staining intensity is present within tumor-associated connective tissue, consistent with extracellular matrix remodeling patterns. The observed staining distribution aligns with reported DCN expression profiles in the Human Protein Atlas.
img
IBA1 Antibody / AIF1 / Allograft inflammatory factor 1 (clone MSVA-955M)
Catalog No : V6070
Applications : IHC
Reactivity : Human
Format : Purified
Recmousemono
Immunohistochemistry of AIF1 Antibody for IHC in human tissue microarrays. Formalin-fixed, paraffin-embedded normal and cancer tissue microarrays demonstrate cytoplasmic HRP-DAB brown staining in macrophages, monocytes, and microglia-rich tissues, while epithelial and stromal cells are largely negative. Staining was performed using clone MSVA-955M. Strong immunoreactivity is observed in spleen, lymph node, tonsil, and inflammatory cell infiltrates across multiple tumor types, consistent with expected Allograft inflammatory factor 1 / IBA1 expression patterns reported in the Human Protein Atlas.
img
Estrogen Receptor alpha Antibody (clone MSVA-564R)
Catalog No : V6071
Applications : IHC
Reactivity : Human
Format : Purified
Recrabbitmono
Immunohistochemistry of Estrogen Receptor antibody for IHC in human tissue microarrays. FFPE human normal and cancer tissues were stained with Estrogen Receptor recombinant rabbit monoclonal antibody clone MSVA-564R. Nuclear staining is observed in hormone-responsive epithelial cells, with strong nuclear positivity in breast epithelium and endometrial glands, including proliferative and secretory endometrium. Placental trophoblastic cells also demonstrate nuclear signal. Most non-hormone-dependent tissues such as skeletal muscle, liver, kidney cortex and medulla, pancreas, thyroid gland, and colon mucosa show little to no nuclear staining. In the cancer tissue gallery, strong nuclear staining is present in subsets of breast carcinoma and endometrioid ovarian carcinoma, while ER negative tumors including colorectal adenocarcinoma, renal cell carcinoma, squamous cell carcinoma of the oral cavity, and prostate adenocarcinoma show absent nuclear labeling. The staining pattern is predominantly nuclear, consistent with Estrogen Receptor alpha localization.
img
Factor XIIIa Antibody / Coagulation factor XIII A chain (clone MSVA-813R)
Catalog No : V6072
Applications : IHC
Reactivity : Human
Format : Purified
Recrabbitmono
Immunohistochemistry of F13A1 Antibody for IHC in human tissue microarrays. FFPE human normal and cancer tissues were stained with Coagulation factor XIII A chain rabbit recombinant monoclonal antibody clone MSVA-813R. Predominant cytoplasmic HRP-DAB brown staining is observed in scattered stromal and histiocytic cells, consistent with known Factor XIII A chain expression in dermal dendrocytes and macrophage-lineage cells. In normal tissues, positive cells are evident within skin, lymph node, and placenta, while most epithelial compartments show minimal staining. In the cancer tissue gallery, cytoplasmic staining is present in subsets of fibrohistiocytic and macrophage-rich tumors, whereas many epithelial malignancies demonstrate absent or very limited labeling. The staining pattern and tissue distribution align with reported expression data from the Human Protein Atlas.
img
FABP1 Antibody / Fatty acid-binding protein 1 (clone MSVA-501M)
Catalog No : V6073
Applications : IHC
Reactivity : Human
Format : Purified
Recmousemono
Immunohistochemistry of FABP1 Antibody for IHC (clone MSVA-501M) in human tissue microarrays. FFPE human normal and cancer tissues were stained with FABP1 antibody for IHC (clone MSVA-501M). In the normal tissue gallery, strong cytoplasmic HRP-DAB brown staining is observed in hepatocytes of liver, consistent with the known high expression of Liver fatty acid binding protein. Prominent cytoplasmic staining is also seen in small intestinal enterocytes and renal proximal tubular epithelial cells, while most other tissues show low to absent staining. In the cancer tissue gallery, hepatocellular carcinoma demonstrates retained cytoplasmic FABP1 expression, whereas many non-hepatic tumors show minimal or negative staining, consistent with reported expression patterns in Human Protein Atlas. The overall staining distribution supports the expected tissue-specific expression profile of FABP1.
img
SATB2 Antibody / Transcription factor SATB2 (clone MSVA-702R)
Catalog No : V6075
Applications : IHC
Reactivity : Human
Format : Purified
Recrabbitmono
Immunohistochemistry of SATB2 antibody in FFPE human tissue microarrays. The recombinant rabbit monoclonal SATB2 antibody (clone MSVA-702R) demonstrates predominantly nuclear staining consistent with SATB2 expression patterns. In normal tissues, strong nuclear staining is observed in colorectal mucosal epithelial cells, while most other tissues show minimal to no staining. In cancer tissues, nuclear positivity is detected in colorectal adenocarcinoma and select tumors of colorectal origin, whereas many non-colorectal malignancies remain negative. These staining patterns are consistent with reported expression data in the Human Protein Atlas.
img
CELA3B Antibody / Chymotrypsin like elastase 3B (clone MSVA-410M)
Catalog No : V6076
Applications : IHC
Reactivity : Human
Format : Purified
Recmousemono
Immunohistochemistry of CELA3B Antibody for IHC in human tissue microarrays. Formalin-fixed, paraffin-embedded normal and cancer tissues were stained using the recombinant mouse monoclonal clone MSVA-410M. Strong cytoplasmic staining is observed in normal pancreatic acinar cells, consistent with the known secretory localization of Chymotrypsin-like elastase family member 3B, while the majority of non-pancreatic tissues are negative. In the cancer panel, pancreatic acinar cell carcinoma shows strong cytoplasmic positivity, whereas most other tumor types are negative, supporting lineage-associated expression. Staining patterns align with published expression data in the Human Protein Atlas.
img
GAD65 Antibody / Glutamate decarboxylase 2 (clone MSVA-602M)
Catalog No : V6079
Applications : IHC
Reactivity : Human
Format : Purified
Recmousemono
Immunohistochemistry of GAD2 Antibody for IHC (clone MSVA-602M) in human tissue microarrays. Formalin-fixed, paraffin-embedded normal and cancer tissues demonstrate selective cytoplasmic staining in neuronal-rich regions of brain tissue, consistent with GABAergic neuron localization of Glutamate decarboxylase 2 / GAD65. Non-neuronal tissues show minimal staining, while tumor samples largely lack significant signal except in rare neuroendocrine or neuronal-derived contexts. The observed distribution pattern across normal and malignant tissues aligns with publicly available expression data from the Human Protein Atlas.
img
GLUL Antibody / Glutamate-ammonia ligase (clone MSVA-750M)
Catalog No : V6080
Applications : IHC
Reactivity : Human
Format : Purified
Immunohistochemistry of GLUL Antibody for IHC in human tissue microarrays. Formalin-fixed, paraffin-embedded normal and cancer tissues demonstrate cytoplasmic HRP-DAB brown staining consistent with Glutamate-ammonia ligase (Glutamine synthetase) expression patterns. In normal liver, staining is accentuated in pericentral hepatocytes, reflecting the characteristic metabolic zonation of GLUL. In brain, astrocytic cytoplasmic staining is observed, while many other normal tissues show low or absent signal. Across cancer tissues, variable cytoplasmic expression is present in selected tumor types, consistent with reported metabolic reprogramming patterns. Clone MSVA-750M was used for immunohistochemistry analysis, and staining distribution aligns with publicly available expression data, including Human Protein Atlas observations.
img
HLA-DRA Antibody / Major histocompatibility complex class II DR alpha chain (clone MSVA-470R)
Catalog No : V6084
Applications : IHC
Reactivity : Human
Format : Purified
Recrabbitmono
HLA-DRA Antibody Recombinant Rabbit MAb for IHC staining of human tissue microarrays (TMAs). Immunohistochemistry analysis using recombinant rabbit monoclonal clone MSVA-470R shows HRP-DAB brown staining consistent with Human leukocyte antigen DR alpha (HLA-DRA), the HLA-DR alpha chain of the MHC class II antigen presentation complex. Staining is observed predominantly in antigen-presenting immune cells including lymphocytes, macrophages, and dendritic cells across multiple tissues, with expression patterns aligning with reported HLA-DR alpha distribution in normal and cancer tissues.
img